|
|
|
|
LEADER |
02137nam a2200265 u 4500 |
001 |
EB000944512 |
003 |
EBX01000000000000000738102 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
150223 r ||| eng |
020 |
|
|
|a 9780309213110
|
245 |
0 |
0 |
|a Assistance to the U.S. Army Medical Research and Materiel Command with preparation of a risk assessment for the Medical Countermeasures Test and Evaluation (MCMT&E) facility at Fort Detrick, Maryland
|h Elektronische Ressource
|b a letter report
|c Committee on Risk Assessment for the Medical Countermeasures Test and Evaluation (MCMT&E) Facility at Fort Detrick, Maryland, Board on Life Sciences, Division on Earth and Life Studies, National Research Council of the National Academies
|
260 |
|
|
|a Washington, DC
|b National Academies Press
|c [2011], 2011
|
300 |
|
|
|a 1 PDF file (36 pages)
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Containment of Biohazards
|
653 |
|
|
|a Laboratories
|
653 |
|
|
|a Risk Assessment
|
710 |
2 |
|
|a National Research Council (U.S.)
|b Committee on Risk Assessment for the Medical Countermeasures Test and Evaluation (MCMT&E) Facility at Fort Detrick, Maryland
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
500 |
|
|
|a Title from PDF t.p
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK209274
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The U.S. Army Medical Research and Materiel Command plans to construct and operate a new Medical Countermeasures Test and Evaluation facility at Fort Detrick in Frederick, Maryland. The facility is intended to handle infectious agents that require safety precautions to the extent of animal biosafety level-3 and -4 and biosafety level-3 and -4. An Army contractor is currently developing a site-specific risk assessment as part of the process to support construction of the proposed facility. This letter report presents an evaluation of the proposed approach to conducting the risk assessment, and offers guidance on the selection of pathogenic agents, scenarios, and assessment approaches
|